Does DABIGATRAN ETEXILATE Cause Dyspnoea? 698 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 698 reports of Dyspnoea have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 1.9% of all adverse event reports for DABIGATRAN ETEXILATE.
698
Reports of Dyspnoea with DABIGATRAN ETEXILATE
1.9%
of all DABIGATRAN ETEXILATE reports
84
Deaths
456
Hospitalizations
How Dangerous Is Dyspnoea From DABIGATRAN ETEXILATE?
Of the 698 reports, 84 (12.0%) resulted in death, 456 (65.3%) required hospitalization, and 57 (8.2%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 698 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Dyspnoea Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB